Aiming at the heart: the capsid protein of dengue virus as a vaccine candidate
Introduction: Dengue fever remains as a health problem worldwide. Although Dengvaxia®, was registered in several countries, the results after the immunization of people suggest an increase of risk in non-immune persons and children younger than 9 years old. No other vaccine is registered so far, thu...
Saved in:
Main Authors: | Laura Lazo (Author), Iris Valdes (Author), Gerardo Guillén (Author), Lisset Hermida (Author), Lázaro Gil (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2019-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Searching for drug leads targeted to the hydrophobic cleft of dengue virus capsid protein
by: Liliane O. Ortlieb, et al.
Published: (2022) -
Looking for Novel Capsid Protein Multimerization Inhibitors of Feline Immunodeficiency Virus
by: Natalia Sierra, et al.
Published: (2018) -
Immunological Analysis of Nodavirus Capsid Displaying the Domain III of Japanese Encephalitis Virus Envelope Protein
by: Kiven Kumar, et al.
Published: (2021) -
IRES-driven expression of the capsid protein of the Venezuelan equine encephalitis virus TC-83 vaccine strain increases its attenuation and safety.
by: Mathilde Guerbois, et al.
Published: (2013) -
Norovirus Capsid Protein-Derived Nanoparticles and Polymers as Versatile Platforms for Antigen Presentation and Vaccine Development
by: Ming Tan, et al.
Published: (2019)